الوصف

[Drug Name]Piroxicam Gel

[Ingredients]This product mianly contains piroxicam *0mg.Accessories for the Carbomer **0,slow blood acid,amine,ethanol,propylene glycol,Polyethylene glycol,EDTA,triethanolamine.

[Properties]This product is yellow-green cream.

[Category]Cymbalta analgesic effect categories of non-prescription medicines drugs.

[Indications]Used to relieve local pain,such as muscle pain,jiont pain,as well as strains,sprains and sports injuries caused by pain and swelling.Can also be used for the symptomatic treatment of osteoarthritis.

[Specifications]*0 grams:*0 mg.

[Usage and dosage]                                                                

External,take appropriate apply on the affected part of skin or joint surface of the skin,2~3 times 1 day.

[Adverse reactions]

Few patients have adverse reactions mild skin redness,itching or a rash can be observed to continue medication,the majority continue to use process disappeared should be discontinued if the symptoms get worse.

 [Taboo]

1.    For other non-steroidal anti-inflammatory drug were banned.

2.    For those who are allergic to disable propylene glycol.

[Notes]

1.    Avoid to contact with eyes and other mucous membranes(such as the mouth,nose,etc.).

2.    Medication are where burning sensation,swelling,etc.should be discontinued,and local drug clean,if necessary,consult the doctor.

3.    Pregnant and lactating women and children is not recommended to the FDA.

4.    Do not use on broken skin and wound infections,and the inappropriate use of a large area.

5.    For those who are allergic to this product is disabled,allergic caution.

6.    Do not use when the product’s properties change.

7.    This product must be placed where children can not catch.

8.    Children use it under the guaidance of the physician.

9.    If you are using other drugs,use before you consult a physician or pharmacist.

[Storage]shading,sealed,in the shade(no more than*0℃) to save.

[Packaging]composite plastic tube packaging , *0g /piece / box

[Validity]*4months

[Implementation of standards]Chinese Pharmacopoeia ***5 Edition.

[Approval number]   Zhunzi H*******8

[Specification revision date